Skip to main content
. 2021 Apr 16;11:656325. doi: 10.3389/fonc.2021.656325

Table 5.

Univariate and multivariate analyses of overall survival in the training cohort.

Characteristics Univariate analysis Multivariate analysis (step)
HR [95%CI] P-value HR [95%CI] P-value
AGE
 >50 years Reference Reference
 ≤50 years 0.98 [0.97, 0.99] 0.003 1.56 [0.91, 2.69] 0.106
PRMARY ORGAN
 Bladder Reference
 Kidney 0.71 [0.36, 1.38] 0.308
 Other 1.10 [0.47, 2.54] 0.831
 Paratesticular 0.70 [0.35, 1.40] 0.319
 Prostate 0.93 [0.41, 2.10] 0.862
GENDER
 Female Reference Reference
 Male 0.55 [0.32, 0.95] 0.031 0.51 [0.30, 0.89] 0.018
SYMPTOM AT PRESENTATION
 No Reference
 Yes 0.78 [0.32, 1.90] 0.585
SYMPTOM DURATION
 >1month Reference
 ≤1month 1.00 [0.97, 1.05] 0.822
TUMOR SIZE
 >5cm Reference
 ≤5cm 1.04 [0.99, 1.09] 0.096
HISTOLOGICAL SUBTYPE
 Liposarcoma Reference Reference
 Leiomyosarcoma 0.67 [0.39, 1.15] 0.148 0.71 [0.37, 1.35] 0.294
 Other 0.75 [0.40, 1.38] 0.350 0.59 [0.27, 1.29] 0.185
 Rhabdomyosarcoma 1.36 [0.72, 2.57] 0.336 1.73 [0.78, 3.85] 0.179
METASTASIS_AT_ENTRY
 No Reference
 Yes 1.00 [0.64, 1.57] 0.990
GRADE
 High Reference
 Low 0.81 [0.46, 1.42] 0.460
SURGERY STATUS
 Surgery and margin negative Reference Reference
 No surgery 36.60 [17.27, 77.57] <0.001 33.04 [14.37, 75.94] <0.001
 Surgery and margin positive 5.20 [2.76, 9.78] <0.001 3.33 [1.70, 6.51] <0.001
CHEMOTHERAPY
 No Reference Reference
 Yes 0.47 [0.30, 0.75] 0.002 0.56 [0.33, 0.95] 0.030
RADIOTHERAPY
 No Reference
 Yes 0.94 [0.60, 1.48] 0.792

Other in Primary organ included four genitourinary sites: ureter, seminal vesicles, and urethra. Other in histological subtype included Ewing′s sarcoma, primitive neuroectodermal tumor, synovial sarcoma, angiosarcoma, fibrosarcoma, malignant peripheral sheath tumor, myo-fibroblastic tumor, osteosarcoma, chondrosarcoma, and undifferentiated sarcoma.